Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 71335-0698 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl713350698
This text contains information on a medication called Losartan, in the form of a green oval tablet with the imprint E46, which contains 50mg of potassium. It is recommended to keep all drugs out of reach of children and to store this medication at room temperature between 20°-25°C (68° T7°F). It comes in a container holding 30 tablets and has a National Drug Code (NDC) of 7133506981 04238301523487. There is also a mention of Buyant Ranch Prcpach Bunbank on the same page, but it is unclear what this is referring to.*
Figure 1 - losartan fig1
This is a data table showing the percentage of patients who achieved the primary endpoint in a study comparing Atenolol and Losartan Potassium. The adjusted risk reduction for the primary endpoint was found to be 13%, with a statistically significant p-value of 0.021. The study was conducted for a period of 66 months and the results were recorded at regular intervals of every 6 months.*
Figure 2 - losartan fig2
This text appears to describe a comparison study of the medications Atenolol and Losartan Potassium. It mentions some kind of risk reduction percentage and a p-value of 0.001. It also appears to show a timeline in months for the study. However, without further context, it is difficult to determine the specifics of the study's findings or what the risk reduction percentage refers to.*
Figure 3 - losartan fig3
This appears to be a table or chart of some sort related to demographic subgroups and their incidence of a primary endpoint event. The table includes data for different age groups, genders, races, and other factors such as potassium levels and history of VD. However, as some of the text is not easily readable due to errors, a more detailed description cannot be provided.*
Figure-4 - losartan fig4
This text represents the results of a clinical trial comparing the use of Losartan Potassium with a placebo in a group of patients. The data shows that out of a total of 100 patients, 60 patients treated with Losartan had a positive outcome (referred to as an "event") while only 40 of those who received the placebo did. This translates into a risk reduction percentage of 16.1%. The p-value, which indicates the statistical significance of the observed difference, is 0.022.*
Chemical Structure - losartan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
